They are two of the most common noncommunicable diseases in the world, and estimates predict one billion people worldwide are affected by obesity while approximately 521million individuals globally live with diabetes
Cell Metab 2019;30:98796.ArticlePubMedPMC 26
$3,588 paid up front with no insurance Key Specs Accepts insurance: Yes Weight loss program included: Yes GLP-1 brand names offered: Ozempic, Zepbound, Mounjaro, Wegovy, Trulicity, Rybelsus, Saxenda, Victoza Type of GLP-1 available: Injectable and oral Cancel any time: No Found offers users a care team led by a physician specializing in weight loss
Expanding Indications: Beyond Obesity and Diabetes The GLP-1 drug pipeline in 2026 reaches well beyond weight management and glycaemic control
Drinking a protein shake before the injection helps me alleviate any nausea
World Health Organization: WHO